LEADER 03666nam  2201141z- 450 
001 9910557363703321
005 20231214133343.0
035   $a(CKB)5400000000042255
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/77121
035   $a(EXLCZ)995400000000042255
100   $a20202201d2021      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aNovel Treatment Strategies for Glioblastoma
210   $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021
215   $a1 electronic resource (268 p.)
311   $a3-0365-2599-8 
311   $a3-0365-2598-X 
330   $aThis book is a compilation of articles that brings together current knowledge from an international team of contributors who are dedicated investigators exploring novel strategies for the treatment of glioblastoma. These articles describe some of the latest concepts that will provide students, researchers and clinicians with an overview of the therapeutic approaches being developed in the field of neuro-oncology to combat this deadly disease.
606   $aMedicine$2bicssc
610   $aglioblastoma
610   $aglioma
610   $atemozolomide
610   $aradiotherapy
610   $aimmunotherapy
610   $anovel therapy
610   $apersonalized treatment
610   $adrug repurposing
610   $ainvasion
610   $ainvadopodia
610   $aion channels
610   $agene therapy
610   $aviral vectors
610   $abrain tumor
610   $ananomedicine
610   $acancer stem cell
610   $atargeted therapy
610   $abrain cancer
610   $acell cycle
610   $adifferentiation
610   $aproliferation
610   $aRAS
610   $aSRGAP2
610   $astem cell
610   $aTP53
610   $aglioblastoma multiforme
610   $aGBM
610   $anerve/glial antigen 2
610   $aNG2
610   $aCK2
610   $aCX-4945
610   $amigration
610   $aCRISPR/Cas9
610   $aanticancer
610   $aanti-angiogenesis
610   $athyrointegrin ?v?3
610   $aPEG
610   $atriazole tetrac
610   $aP-bi-TAT
610   $aP-m-TAT
610   $atetrac
610   $aone-carbon metabolism
610   $ade novo purine synthesis
610   $ametabolic reprogramming
610   $ametabolic treatment
610   $avaccine
610   $aimmune checkpoint inhibitors
610   $achimeric antigen receptor (CAR) T cells
610   $aglioblastoma (GB)
610   $aprolyl-oligopeptidase (POP)
610   $avascular endothelial growth factor (VEGF)
610   $atransforming growth factor-? (TGF-?)
610   $aangiopoietin (Ang)
610   $aendothelial nitric oxide synthase (eNOS)
610   $anewly diagnosed glioblastoma
610   $arecurrent glioblastoma
610   $anew trial design
610   $adrug-inducible gene expression
610   $aMardepodect
610   $aRegorafenib
610   $adrug targets
610   $atumor antigens
610   $arenin-angiotensin system
610   $apluripotent stem cells
610   $aorganoids
610   $acancer stem cells
610   $acancer stem cell niche
610   $atumor microenvironment
615  7$aMedicine
700   $aStylli$b Stanley$4edt$01314841
702   $aStylli$b Stanley$4oth
906   $aBOOK
912   $a9910557363703321
996   $aNovel Treatment Strategies for Glioblastoma$93032034
997   $aUNINA